Altaf Mohammed

2.5k total citations
96 papers, 1.9k citations indexed

About

Altaf Mohammed is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Altaf Mohammed has authored 96 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 38 papers in Molecular Biology and 28 papers in Cancer Research. Recurrent topics in Altaf Mohammed's work include Inflammatory mediators and NSAID effects (19 papers), Cancer, Lipids, and Metabolism (17 papers) and Pancreatic and Hepatic Oncology Research (14 papers). Altaf Mohammed is often cited by papers focused on Inflammatory mediators and NSAID effects (19 papers), Cancer, Lipids, and Metabolism (17 papers) and Pancreatic and Hepatic Oncology Research (14 papers). Altaf Mohammed collaborates with scholars based in United States, Malaysia and Qatar. Altaf Mohammed's co-authors include Chinthalapally V. Rao, Naveena B. Janakiram, Stan Lightfoot, Vernon E. Steele, Naveena B. Janakiram, Venkateshwar Madka, Misty Brewer, Jagan M.R. Patlolla, Laura Biddick and Qian Li and has published in prestigious journals such as Gastroenterology, Cancer Research and Scientific Reports.

In The Last Decade

Altaf Mohammed

95 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Altaf Mohammed United States 27 888 661 471 247 246 96 1.9k
Gi‐Ming Lai Taiwan 28 1.3k 1.5× 828 1.3× 493 1.0× 229 0.9× 237 1.0× 57 2.5k
Masako Ochiai Japan 32 1.4k 1.6× 771 1.2× 1.0k 2.2× 122 0.5× 266 1.1× 97 2.8k
Haiquan Qiao China 29 1.2k 1.4× 504 0.8× 710 1.5× 77 0.3× 234 1.0× 60 2.3k
Sung‐Dae Cho South Korea 25 1.3k 1.5× 397 0.6× 307 0.7× 256 1.0× 61 0.2× 103 2.0k
Byung‐Doo Hwang South Korea 24 862 1.0× 208 0.3× 314 0.7× 268 1.1× 98 0.4× 73 1.7k
Ji Hoon Jung South Korea 31 1.5k 1.7× 472 0.7× 464 1.0× 271 1.1× 261 1.1× 116 2.6k
Yunguang Tong China 19 796 0.9× 241 0.4× 331 0.7× 80 0.3× 99 0.4× 29 1.4k
Changgang Sun China 33 1.4k 1.6× 474 0.7× 820 1.7× 150 0.6× 111 0.5× 140 2.7k
Tzyh‐Chyuan Hour Taiwan 27 1.2k 1.3× 375 0.6× 311 0.7× 176 0.7× 107 0.4× 73 2.0k
Marianna Lauricella Italy 28 1.3k 1.5× 311 0.5× 379 0.8× 123 0.5× 62 0.3× 80 2.1k

Countries citing papers authored by Altaf Mohammed

Since Specialization
Citations

This map shows the geographic impact of Altaf Mohammed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Altaf Mohammed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Altaf Mohammed more than expected).

Fields of papers citing papers by Altaf Mohammed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Altaf Mohammed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Altaf Mohammed. The network helps show where Altaf Mohammed may publish in the future.

Co-authorship network of co-authors of Altaf Mohammed

This figure shows the co-authorship network connecting the top 25 collaborators of Altaf Mohammed. A scholar is included among the top collaborators of Altaf Mohammed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Altaf Mohammed. Altaf Mohammed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biswas, Kajal, Altaf Mohammed, Shyam K. Sharan, & Robert H. Shoemaker. (2023). Genetically engineered mouse models for hereditary cancer syndromes. Cancer Science. 114(5). 1800–1815. 2 indexed citations
2.
Mazumdar, Abhijit, Jamal Hill, Jitesh D. Kawedia, et al.. (2022). Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer. Cancer Prevention Research. 15(12). 791–802. 4 indexed citations
3.
Madka, Venkateshwar, Gaurav Kumar, Gopal Pathuri, et al.. (2021). Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat. Cancer Prevention Research. 14(11). 1009–1020. 6 indexed citations
4.
Mohammed, Altaf, Roderick H. Dashwood, Sally E. Dickinson, et al.. (2021). Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report. Journal of Cancer Prevention. 26(4). 309–317. 1 indexed citations
5.
Rajendran, Praveen, Wan Mohaiza Dashwood, Michelle I. Savage, et al.. (2020). Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP). Cancer Prevention Research. 14(3). 325–336. 12 indexed citations
6.
Madka, Venkateshwar, Gaurav Kumar, Gopal Pathuri, et al.. (2019). Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model. Cancer Prevention Research. 13(2). 185–194. 9 indexed citations
7.
Mohammed, Altaf, Mark Steven Miller, Ronald A. Lubet, et al.. (2019). Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers. Cancer Prevention Research. 13(3). 273–282. 8 indexed citations
8.
Rao, Chinthalapally V., Yuting Zhang, Laura Biddick, et al.. (2016). Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1 −/+ Mice. Cancer Research. 76(3). 630–642. 19 indexed citations
9.
Rao, Chinthalapally V., Naveena B. Janakiram, Venkateshwar Madka, et al.. (2016). Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer. Cancer Research. 76(7). 1965–1974. 41 indexed citations
10.
Janakiram, Naveena B., Altaf Mohammed, Stan Lightfoot, et al.. (2015). Improved Innate Immune Responses by Frondanol A5, a Sea Cucumber Extract, Prevent Intestinal Tumorigenesis. Cancer Prevention Research. 8(4). 327–337. 25 indexed citations
11.
Madka, Venkateshwar, Altaf Mohammed, Qian Li, et al.. (2015). Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo. Cancer Prevention Research. 9(1). 53–62. 13 indexed citations
12.
Patlolla, Jagan M.R., Levy Kopelovich, Qian Li, et al.. (2015). Early and delayed intervention with Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice. Oncology Reports. 34(6). 2925–2934. 11 indexed citations
13.
Mohammed, Altaf, Naveena B. Janakiram, Venkateshwar Madka, et al.. (2014). Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling. Cancer Prevention Research. 7(12). 1198–1209. 55 indexed citations
14.
Janakiram, Naveena B., Altaf Mohammed, Misty Brewer, et al.. (2014). Raloxifene and Antiestrogenic Gonadorelin Inhibits Intestinal Tumorigenesis by Modulating Immune Cells and Decreasing Stem-like Cells. Cancer Prevention Research. 7(3). 300–309. 10 indexed citations
15.
Sureban, Sripathi M., Randal May, Stan Lightfoot, et al.. (2011). DCAMKL-1 Regulates Epithelial–Mesenchymal Transition in Human Pancreatic Cells through a miR-200a –Dependent Mechanism. Cancer Research. 71(6). 2328–2338. 169 indexed citations
16.
Mohammed, Altaf, Naveena B. Janakiram, Qian Li, et al.. (2011). Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCMin/+ Mice by Licofelone, a Novel Dual 5-LOX/COX Inhibitor: Potential Implications for Human Colon Cancer Prevention. Cancer Prevention Research. 4(12). 2015–2026. 51 indexed citations
17.
Janakiram, Naveena B., Altaf Mohammed, & Chinthalapally V. Rao. (2011). Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer and Metastasis Reviews. 30(3-4). 507–523. 70 indexed citations
18.
Mohammed, Altaf, Naveena B. Janakiram, Venkateshwar Madka, et al.. (2010). The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model. Cancer Prevention Research. 3(11). 1417–1426. 45 indexed citations
19.
Swamy, Malisetty V., et al.. (2008). Prevention and Treatment of Pancreatic Cancer by Curcumin in Combination With Omega-3 Fatty Acids. Nutrition and Cancer. 60(sup1). 81–89. 73 indexed citations
20.
Mohammed, Altaf, et al.. (2004). Senseval-3 logic forms: A system and possible improvements.. Meeting of the Association for Computational Linguistics. 163–166. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gi‐Ming Lai Breakdown of academic impact, for papers by Masako Ochiai Breakdown of academic impact, for papers by Haiquan Qiao Breakdown of academic impact, for papers by Sung‐Dae Cho Breakdown of academic impact, for papers by Byung‐Doo Hwang Breakdown of academic impact, for papers by Ji Hoon Jung Breakdown of academic impact, for papers by Yunguang Tong Breakdown of academic impact, for papers by Changgang Sun Breakdown of academic impact, for papers by Tzyh‐Chyuan Hour Breakdown of academic impact, for papers by Marianna Lauricella
Rankless by CCL
2026